Documentos relacionados

1. Efficacy and safety of switching from nevirapine immediate-release twice daily to nevirapine extended-release once daily in virologically suppressed HIV-infected patients: a retrospective cohort study in Taiwan.
2. Urine nevirapine as a predictor of antiretroviral adherence.
3. Pediatric Antiretroviral Therapeutic Drug Monitoring: A Five and a Half Year Experience from a South African Tertiary Hospital.
4. Dried plasma/blood spots for monitoring antiretroviral treatment efficacy and pharmacokinetics: a cross-sectional study in rural Burundi.
5. Dosage optimization of treatments using population pharmacokinetic modeling and simulation.
6. Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz.
7. [Evidence-based therapeutic drug monitoring for nevirapine].
8. Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine.
9. [Modeling of antiretroviral response from taxonomy of CD4 cells count trajectories in profound immunodeficiency setting].
10. Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.